(800)525-7111 Free Consultation

Dangerous Drugs

FDA Updates Tepezza Warning Label Amidst Lawsuits

August 2, 2023   |  
Tepezza's Updated Warning Label The U.S. Food and Drug Administration (FDA) has recently updated the warning label for Tepezza, a drug used to treat thyroid eye disease (TED). The new label now includes a section that highlights the risk of severe hearing impairment, including permanent hearing loss, a warning that...
Read More

What to Expect in the 1st Paraquat Bellwether Trial

January 23, 2023   |  
1st Paraquat Trial to Begin in October 2023 Paraquat, a widely used commercial and consumer herbicide, has been linked to Parkinson's disease in recent years. It has been used for decades in the agricultural industry, but scientists have only started to uncover this hazardous chemical's true dangers. As a result,...
Read More

Unilever Issues Dry Shampoo Recall for Cancer Risk Due to Benzene Contamination

October 25, 2022   |  
Benzene in Dry Shampoos May Cause Cancer, Prompting Major Recall Consumer products giant Unilever has issued a wide-ranging recall of popular spray-on dry shampoos due to benzene contamination, warning that the dangerous chemical may cause cancer. In a joint recall announcement with the Food & Drug Administration (FDA), Unilever said...
Read More

Paraquat Lawsuit MDL Status and Update

August 19, 2022   |  
Paraquat Litigation Update - August 2022 Manufacturers and distributors of Paraquat, a popular weed killer, are currently facing over 1000 lawsuits alleging they neglected to inform consumers of the dangers connected to paraquat herbicides. The Paraquat MDL (multi-district litigation) judge has allowed most of these claims to proceed, with the...
Read More

1st Paraquat Bellwether Trial Scheduled for Late 2022

May 17, 2022   |  
Paraquat Lawsuits Will Go to Trial in November 2022 In June of 2021, the Judicial Panel of Multidistrict Litigation in the Southern District of Illinois consolidated all Paraquat lawsuits filed against chemical manufacturer Syngenta into new multidistrict litigation (MDL). The first “bellwether” Paraquat trial has now been scheduled for November...
Read More

Judge Denies Defense Motions, Allows Most Paraquat Lawsuits to Advance

March 3, 2022   |  
Defendants’ Motions Denied in Paraquat Litigation A federal judge in southern Illinois has ruled that hundreds of paraquat lawsuits can proceed against Syngenta Corp. and Chevron USA, the major manufacturers and distributors of the herbicide (weed killer) in the United States. Chief U.S. District Judge Nancy Rosenstengel denied motions filed...
Read More

Does Paraquat Cause Kidney Disease?

January 10, 2022   |  
Paraquat is an herbicide that has been used to rid everything from home gardens to commercial farms of weeds since the 1960s. However, this popular weed killer has recently been linked to an increased risk for a wide variety of health problems. Hundreds of lawsuits have been filed alleging that...
Read More

Who Made Zantac?

December 8, 2021   |  
Zantac was once one of the most popular heartburn medications on the market. However, after a probable human carcinogen, N-Nitrosodimethylamine (NDMA), was found in Zantac, it triggered a slew of Zantac lawsuits and a nationwide recall. Now, consumers have deep concerns about the safety of this product. Of course, the...
Read More

Elmiron MDL Update: What’s Happening with Elmiron Lawsuits?

December 11, 2020   |  
UPDATE: Elmiron lawsuits alleging that Elmiron causes eye damage have been consolidated into multi-district litigation (MDL) in the District Court of New Jersey. The U.S. Judicial Panel on Multidistrict Litigation transferred almost 130 lawsuits to the court of District Court Judge Brian Martinotti on December 15, 2020. IMPORTANT: As of...
Read More

Metformin Recall Continues After NDMA Contamination Detected

October 9, 2020   |  
Drug manufacturers are moving forward with continued metformin recalls after the Food and Drug Administration (FDA) recently announced the popular diabetes medicine is contaminated with NDMA, a potentially cancer-causing chemical. India-based manufacturer Marksans Pharma Limited joins seven other pharmaceutical companies that have issued metformin recalls due to NDMA contamination. The...
Read More